ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 274 filers reported holding ALKERMES PLC in Q4 2022. The put-call ratio across all filers is 2.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,564,753 | -18.4% | 55,904 | -8.7% | 0.37% | -9.5% |
| Q2 2023 | $1,916,568 | +4.8% | 61,242 | -5.6% | 0.41% | +1.7% |
| Q1 2023 | $1,828,869 | +1.8% | 64,865 | -5.3% | 0.40% | 0.0% |
| Q4 2022 | $1,797,361 | +13.6% | 68,497 | -3.2% | 0.40% | +10.4% |
| Q3 2022 | $1,582,000 | -18.2% | 70,795 | +9.1% | 0.37% | -10.1% |
| Q2 2022 | $1,933,000 | +4.3% | 64,866 | -7.9% | 0.41% | +46.4% |
| Q1 2022 | $1,853,000 | – | 70,431 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 8,964,640 | $234,246,043 | 27.88% |
| Krensavage Asset Management, LLC | 1,401,783 | $36,629 | 11.32% |
| Hardman Johnston Global Advisors LLC | 5,561,806 | $145,329,991 | 5.69% |
| 13D Management LLC | 383,584 | $10,023,050 | 5.27% |
| Prosight Management, LP | 341,521 | $8,923,944 | 4.87% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $15,483,230 | 4.78% |
| Tamarack Advisers, LP | 275,000 | $7,185,750 | 3.70% |
| Ally Bridge Group (NY) LLC | 142,002 | $3,710,512 | 3.61% |
| HealthCor Management, L.P. | 110,000 | $2,874,300 | 2.63% |
| Price Jennifer C. | 360,600 | $9,422,478 | 2.25% |